Absci is a generative AI drug creation company leveraging artificial intelligence and synthetic biology to design and develop next-generation biologic therapeutics. Its Integrated Drug Creation platform combines proprietary data, AI models, and scalable wet lab validation to accelerate drug discovery, optimize biologics, and enable therapies against challenging targets for the biopharmaceutical industry.
The posting states 'Support new process enhancements and/or system implementations to address accounting, planning, and reporting needs' and requires experience with ERP and other accounting-related systems (specifically naming NetSuite, Coupa, Workiva, and Shareworks), indicating an upcoming or ongoing software/system evaluation/implementation.